BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 21243582)

  • 1. Current approaches to discover marine antileishmanial natural products.
    Tempone AG; Martins de Oliveira C; Berlinck RG
    Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The recent research progress of chemistry of marine natural products].
    Shi QW; Li LG; Wang YF; Huo CH; Zhang ML
    Yao Xue Xue Bao; 2010 Oct; 45(10):1212-23. PubMed ID: 21348298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the fight against leishmaniasis with natural products.
    Akendengue B; Ngou-Milama E; Laurens A; Hocquemiller R
    Parasite; 1999 Mar; 6(1):3-8. PubMed ID: 10229931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational approaches for drug designing against leishmaniasis.
    Shukla AK; Singh BK; Patra S; Dubey VK
    Appl Biochem Biotechnol; 2010 Apr; 160(8):2208-18. PubMed ID: 19756413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial peptides for leishmaniasis.
    Cobb SL; Denny PW
    Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manzamine alkaloids as antileishmanial agents: A review.
    Ashok P; Lathiya H; Murugesan S
    Eur J Med Chem; 2015 Jun; 97():928-36. PubMed ID: 25023608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in antileishmanial drug development.
    Davis AJ; Kedzierski L
    Curr Opin Investig Drugs; 2005 Feb; 6(2):163-9. PubMed ID: 15751739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antileishmanial profile of some novel terpenyl pyrimidines.
    Pandey S; Suryawanshi SN; Gupta S; Srivastava VM
    Eur J Med Chem; 2004 Nov; 39(11):969-73. PubMed ID: 15501546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs.
    Pulido SA; Muñoz DL; Restrepo AM; Mesa CV; Alzate JF; Vélez ID; Robledo SM
    Acta Trop; 2012 Apr; 122(1):36-45. PubMed ID: 22155571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant natural products with leishmanicidal activity.
    Chan-Bacab MJ; Peña-Rodríguez LM
    Nat Prod Rep; 2001 Dec; 18(6):674-88. PubMed ID: 11820764
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
    Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
    Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of natural products with antileishmanial activity.
    Rocha LG; Almeida JR; Macêdo RO; Barbosa-Filho JM
    Phytomedicine; 2005 Jun; 12(6-7):514-35. PubMed ID: 16008131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives.
    Robledo S; Osorio E; Muñoz D; Jaramillo LM; Restrepo A; Arango G; Vélez I
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1652-5. PubMed ID: 15793164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modes of action of Leishmanicidal antimicrobial peptides.
    Marr AK; McGwire BS; McMaster WR
    Future Microbiol; 2012 Sep; 7(9):1047-59. PubMed ID: 22953706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
    Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
    Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycobiology of the Leishmania parasite and emerging targets for antileishmanial drug discovery.
    Chandra S; Ruhela D; Deb A; Vishwakarma RA
    Expert Opin Ther Targets; 2010 Jul; 14(7):739-57. PubMed ID: 20536412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marine Algae as Source of Novel Antileishmanial Drugs: A Review.
    Tchokouaha Yamthe LR; Appiah-Opong R; Tsouh Fokou PV; Tsabang N; Fekam Boyom F; Nyarko AK; Wilson MD
    Mar Drugs; 2017 Oct; 15(11):. PubMed ID: 29109372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, leishmanicidal evaluation and molecular docking simulations of piperidine alkaloids from Senna spectabilis.
    Lacerda RBM; Freitas TR; Martins MM; Teixeira TL; da Silva CV; Candido PA; Oliveira RJ; Júnior CV; Bolzani VDS; Danuello A; Pivatto M
    Bioorg Med Chem; 2018 Dec; 26(22):5816-5823. PubMed ID: 30413343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: a review.
    Da Silva BJM; Hage AAP; Silva EO; Rodrigues APD
    J Integr Med; 2018 Jul; 16(4):211-222. PubMed ID: 29691188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.